Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective

The burden of Parkinson’s disease (PD) continues to grow at an unsustainable pace particularly given that it now represents the fastest growing brain disease. Despite seminal discoveries in genetics and pathogenesis, people living with PD oftentimes wait years to obtain an accurate diagnosis and hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, Diane, Badawy, Reham, Mathur, Soania, Tome, Maria, Rochester, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385507/
https://www.ncbi.nlm.nih.gov/pubmed/33579873
http://dx.doi.org/10.3233/JPD-202428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385507/
https://www.ncbi.nlm.nih.gov/pubmed/33579873
http://dx.doi.org/10.3233/JPD-202428

Ejemplares similares